SOL SOLACI Performed a New Intervention During the Ecuador Sessions 2020

A new charitable case was featured at the Ecuador XL SOLACI Sessions 2020. At the CardioCentro Manta / Angiomanabí Clinic in Manta, Ecuador, physicians performed a successful closure of ductus arteriosus type A1 with an Amplatzer ADO I device (antegrade access). The patient was a 1-year old child admitted with a diagnosis of persistent ductus arteriosus. The case was sponsored by C.G MED.

Thus, SOLACI’s SOLidario (which means ‘solidary’ in Spanish) Program continues with its mission: facilitating the access to percutaneous and/or cardiovascular procedures to Latin American patients without the medical coverage or economic resources for them.

Below, the case presentation during the Ecuador Sessions 2020.

caso-solidario-jornadas-ecuador-2020

SOLACI’s SOLidario Program Against the COVID-19 Pandemic

Today, more than ever, the members of SOLACI’s SOLidario Program want our Latin American colleagues to know that we are in this together. As everyone knows, the primary purpose of this program is to grant our patients access to interventional procedures in renowned medical centers. Specialists who are SOLACI members perform such interventions in collaboration with other internationally famed experts.

The current situation would have been hard to imagine a short time ago. This pandemic represents an unimaginable challenge, but we will work together so that we can lead the resistance against the disease, directing our best efforts to aid those most vulnerable.

Dr. Marcelo Halac.
Head of SOLACI’s SOLidario Program.


About SOL SOLACI

programa solidario solaci

SOLACI’s SOLidario Program is a facilitator connecting the patient, the institution, the local scientific community, and the specialist with local suppliers in each country so that the performing team can count with the adequate supply of elements, drugs, and/or endovascular devices for a successful procedure.

Created by a group of adult and pediatric interventional cardiologists who are SOLACI members, SOLACI SOL seeks to facilitate the access to percutaneous therapeutic and diagnostic cardiovascular procedures, conducted in renowned medical centers by specialists who are SOLACI members, to patients in Latin America and the Caribbean who lack the medical coverage or economic resources for them.

In case of questions about SOLACI’s SOLidario Program, contact us at jornadas@solaci.org


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....